 | • レポートコード：QYR2104Z0499 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、萎縮性胃炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（コーティング剤、抗生物質、ビタミンB-12）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・萎縮性胃炎治療の市場動向 ・企業の競争状況、市場シェア ・萎縮性胃炎治療の種類別市場規模（コーティング剤、抗生物質、ビタミンB-12） ・萎縮性胃炎治療の用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン薬局） ・萎縮性胃炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・萎縮性胃炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・萎縮性胃炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・萎縮性胃炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・萎縮性胃炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Takeda Pharmaceutical Company Limited、PERNIX Therapeutics、Perrigo Pharmaceutical、Teva Pharmaceutical） ・結論 |
Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity directed against gastric glandular cell. Symptoms include stomach pain, loss of appetite, nausea, unexpected weight loss, iron deficiency anemia. There is a high chance for the development of pernicious anemia in autoimmune atrophic gastritis Individual due to the loss of anti-intrinsic antibodies and parietal cell mass. Atrophic gastritis associated with H. Pylori are at high risk of developing gastric carcinoma and is frequently asymptomatic. Individuals associated with chronic atrophic gastritis develop hypergastrinemia and low gastric acid output which may lead to carcinoid tumors and enterochromaffin-like cell hyperplasia. Atrophic gastritis develops at childhood and if, it is left untreated atrophic gastritis progress throughout the lifespan. Treatment mainly includes antibiotics for eliminating H. Pylori bacteria. Symptomatic treatment includes vitamin B-12 injections. Proton pump inhibitors used to control the acidity of the stomach. Autoimmune atrophic gastritis associated with gastric polyps, pernicious anemia, and adenocarcinoma. Atrophic gastritis diagnosed by low levels of B-12, low levels of pepsinogen, high levels of gastrin and intrinsic factors.
Atrophic gastritis is associated with loss of gastric gland and is a progressive condition with the replacement of metaplasia. It is asymptomatic and associated with large complications like gastric carcinoma, hyperplasia, hypergastrinemia, increased risk of heart attack in elderly. The frequency of atrophic gastritis is unknown due to it is mostly asymptomatic. Atrophic gastritis is extremely common and is highly prevalent in different parts of the globe. In atrophic gastritis, eradication of H. Pylori is highly complicated, and it requires follow-up for several years. Eradication of H. Pylori reduces the risk of developing cancers in late stages. Mortality and morbidity associated with atrophic gastritis are depended on underlying complications of diseases. Atrophic gastritis requires a continuous management because recurrence of illness is high. All these factors act as a driver in the robust growth of the atrophic gastritis treatment market.
Market Analysis and Insights: Global Atrophic Gastritis Treatment Market
The global Atrophic Gastritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Atrophic Gastritis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Atrophic Gastritis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Atrophic Gastritis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Atrophic Gastritis Treatment market.
Global Atrophic Gastritis Treatment Scope and Market Size
Atrophic Gastritis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Atrophic Gastritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Coating Agents
Antibiotics
Vitamin B-12
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Takeda Pharmaceutical Company Limited
PERNIX Therapeutics
Perrigo Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Atrophic Gastritis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Coating Agents
1.2.3 Antibiotics
1.2.4 Vitamin B-12
1.3 Market by Application
1.3.1 Global Atrophic Gastritis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.3.5 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Atrophic Gastritis Treatment Market Perspective (2016-2027)
2.2 Atrophic Gastritis Treatment Growth Trends by Regions
2.2.1 Atrophic Gastritis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Atrophic Gastritis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Atrophic Gastritis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Atrophic Gastritis Treatment Industry Dynamic
2.3.1 Atrophic Gastritis Treatment Market Trends
2.3.2 Atrophic Gastritis Treatment Market Drivers
2.3.3 Atrophic Gastritis Treatment Market Challenges
2.3.4 Atrophic Gastritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Atrophic Gastritis Treatment Players by Revenue
3.1.1 Global Top Atrophic Gastritis Treatment Players by Revenue (2016-2021)
3.1.2 Global Atrophic Gastritis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Atrophic Gastritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Atrophic Gastritis Treatment Revenue
3.4 Global Atrophic Gastritis Treatment Market Concentration Ratio
3.4.1 Global Atrophic Gastritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Atrophic Gastritis Treatment Revenue in 2020
3.5 Atrophic Gastritis Treatment Key Players Head office and Area Served
3.6 Key Players Atrophic Gastritis Treatment Product Solution and Service
3.7 Date of Enter into Atrophic Gastritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Atrophic Gastritis Treatment Breakdown Data by Type
4.1 Global Atrophic Gastritis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Atrophic Gastritis Treatment Forecasted Market Size by Type (2022-2027)
5 Atrophic Gastritis Treatment Breakdown Data by Application
5.1 Global Atrophic Gastritis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Atrophic Gastritis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Atrophic Gastritis Treatment Market Size (2016-2027)
6.2 North America Atrophic Gastritis Treatment Market Size by Type
6.2.1 North America Atrophic Gastritis Treatment Market Size by Type (2016-2021)
6.2.2 North America Atrophic Gastritis Treatment Market Size by Type (2022-2027)
6.2.3 North America Atrophic Gastritis Treatment Market Size by Type (2016-2027)
6.3 North America Atrophic Gastritis Treatment Market Size by Application
6.3.1 North America Atrophic Gastritis Treatment Market Size by Application (2016-2021)
6.3.2 North America Atrophic Gastritis Treatment Market Size by Application (2022-2027)
6.3.3 North America Atrophic Gastritis Treatment Market Size by Application (2016-2027)
6.4 North America Atrophic Gastritis Treatment Market Size by Country
6.4.1 North America Atrophic Gastritis Treatment Market Size by Country (2016-2021)
6.4.2 North America Atrophic Gastritis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Atrophic Gastritis Treatment Market Size (2016-2027)
7.2 Europe Atrophic Gastritis Treatment Market Size by Type
7.2.1 Europe Atrophic Gastritis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Atrophic Gastritis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Atrophic Gastritis Treatment Market Size by Type (2016-2027)
7.3 Europe Atrophic Gastritis Treatment Market Size by Application
7.3.1 Europe Atrophic Gastritis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Atrophic Gastritis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Atrophic Gastritis Treatment Market Size by Application (2016-2027)
7.4 Europe Atrophic Gastritis Treatment Market Size by Country
7.4.1 Europe Atrophic Gastritis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Atrophic Gastritis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Atrophic Gastritis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Atrophic Gastritis Treatment Market Size by Type
8.2.1 Asia-Pacific Atrophic Gastritis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Atrophic Gastritis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Atrophic Gastritis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Atrophic Gastritis Treatment Market Size by Application
8.3.1 Asia-Pacific Atrophic Gastritis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Atrophic Gastritis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Atrophic Gastritis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Atrophic Gastritis Treatment Market Size by Region
8.4.1 Asia-Pacific Atrophic Gastritis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Atrophic Gastritis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Atrophic Gastritis Treatment Market Size (2016-2027)
9.2 Latin America Atrophic Gastritis Treatment Market Size by Type
9.2.1 Latin America Atrophic Gastritis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Atrophic Gastritis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Atrophic Gastritis Treatment Market Size by Type (2016-2027)
9.3 Latin America Atrophic Gastritis Treatment Market Size by Application
9.3.1 Latin America Atrophic Gastritis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Atrophic Gastritis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Atrophic Gastritis Treatment Market Size by Application (2016-2027)
9.4 Latin America Atrophic Gastritis Treatment Market Size by Country
9.4.1 Latin America Atrophic Gastritis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Atrophic Gastritis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Atrophic Gastritis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Atrophic Gastritis Treatment Market Size by Type
10.2.1 Middle East & Africa Atrophic Gastritis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Atrophic Gastritis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Atrophic Gastritis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Atrophic Gastritis Treatment Market Size by Application
10.3.1 Middle East & Africa Atrophic Gastritis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Atrophic Gastritis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Atrophic Gastritis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Atrophic Gastritis Treatment Market Size by Country
10.4.1 Middle East & Africa Atrophic Gastritis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Atrophic Gastritis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takeda Pharmaceutical Company Limited
11.1.1 Takeda Pharmaceutical Company Limited Company Details
11.1.2 Takeda Pharmaceutical Company Limited Business Overview
11.1.3 Takeda Pharmaceutical Company Limited Atrophic Gastritis Treatment Introduction
11.1.4 Takeda Pharmaceutical Company Limited Revenue in Atrophic Gastritis Treatment Business (2016-2021)
11.1.5 Takeda Pharmaceutical Company Limited Recent Development
11.2 PERNIX Therapeutics
11.2.1 PERNIX Therapeutics Company Details
11.2.2 PERNIX Therapeutics Business Overview
11.2.3 PERNIX Therapeutics Atrophic Gastritis Treatment Introduction
11.2.4 PERNIX Therapeutics Revenue in Atrophic Gastritis Treatment Business (2016-2021)
11.2.5 PERNIX Therapeutics Recent Development
11.3 Perrigo Pharmaceutical
11.3.1 Perrigo Pharmaceutical Company Details
11.3.2 Perrigo Pharmaceutical Business Overview
11.3.3 Perrigo Pharmaceutical Atrophic Gastritis Treatment Introduction
11.3.4 Perrigo Pharmaceutical Revenue in Atrophic Gastritis Treatment Business (2016-2021)
11.3.5 Perrigo Pharmaceutical Recent Development
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Company Details
11.4.2 Teva Pharmaceutical Business Overview
11.4.3 Teva Pharmaceutical Atrophic Gastritis Treatment Introduction
11.4.4 Teva Pharmaceutical Revenue in Atrophic Gastritis Treatment Business (2016-2021)
11.4.5 Teva Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Atrophic Gastritis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Coating Agents
Table 3. Key Players of Antibiotics
Table 4. Key Players of Vitamin B-12
Table 5. Global Atrophic Gastritis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Atrophic Gastritis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Atrophic Gastritis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Atrophic Gastritis Treatment Market Share by Regions (2016-2021)
Table 9. Global Atrophic Gastritis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Atrophic Gastritis Treatment Market Share by Regions (2022-2027)
Table 11. Atrophic Gastritis Treatment Market Trends
Table 12. Atrophic Gastritis Treatment Market Drivers
Table 13. Atrophic Gastritis Treatment Market Challenges
Table 14. Atrophic Gastritis Treatment Market Restraints
Table 15. Global Atrophic Gastritis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Atrophic Gastritis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Atrophic Gastritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atrophic Gastritis Treatment as of 2020)
Table 18. Ranking of Global Top Atrophic Gastritis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Atrophic Gastritis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Atrophic Gastritis Treatment Product Solution and Service
Table 22. Date of Enter into Atrophic Gastritis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Atrophic Gastritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Atrophic Gastritis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Atrophic Gastritis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Atrophic Gastritis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Atrophic Gastritis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Atrophic Gastritis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Atrophic Gastritis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Atrophic Gastritis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Atrophic Gastritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Atrophic Gastritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Atrophic Gastritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Atrophic Gastritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Atrophic Gastritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Atrophic Gastritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Atrophic Gastritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Atrophic Gastritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Atrophic Gastritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Atrophic Gastritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Atrophic Gastritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Atrophic Gastritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Atrophic Gastritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Atrophic Gastritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Atrophic Gastritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Atrophic Gastritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Atrophic Gastritis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Atrophic Gastritis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Atrophic Gastritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Atrophic Gastritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Atrophic Gastritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Atrophic Gastritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Atrophic Gastritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Atrophic Gastritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Atrophic Gastritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Atrophic Gastritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Atrophic Gastritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Atrophic Gastritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Atrophic Gastritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Atrophic Gastritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Takeda Pharmaceutical Company Limited Company Details
Table 63. Takeda Pharmaceutical Company Limited Business Overview
Table 64. Takeda Pharmaceutical Company Limited Atrophic Gastritis Treatment Product
Table 65. Takeda Pharmaceutical Company Limited Revenue in Atrophic Gastritis Treatment Business (2016-2021) & (US$ Million)
Table 66. Takeda Pharmaceutical Company Limited Recent Development
Table 67. PERNIX Therapeutics Company Details
Table 68. PERNIX Therapeutics Business Overview
Table 69. PERNIX Therapeutics Atrophic Gastritis Treatment Product
Table 70. PERNIX Therapeutics Revenue in Atrophic Gastritis Treatment Business (2016-2021) & (US$ Million)
Table 71. PERNIX Therapeutics Recent Development
Table 72. Perrigo Pharmaceutical Company Details
Table 73. Perrigo Pharmaceutical Business Overview
Table 74. Perrigo Pharmaceutical Atrophic Gastritis Treatment Product
Table 75. Perrigo Pharmaceutical Revenue in Atrophic Gastritis Treatment Business (2016-2021) & (US$ Million)
Table 76. Perrigo Pharmaceutical Recent Development
Table 77. Teva Pharmaceutical Company Details
Table 78. Teva Pharmaceutical Business Overview
Table 79. Teva Pharmaceutical Atrophic Gastritis Treatment Product
Table 80. Teva Pharmaceutical Revenue in Atrophic Gastritis Treatment Business (2016-2021) & (US$ Million)
Table 81. Teva Pharmaceutical Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Atrophic Gastritis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Coating Agents Features
Figure 3. Antibiotics Features
Figure 4. Vitamin B-12 Features
Figure 5. Global Atrophic Gastritis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Drug Stores Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Atrophic Gastritis Treatment Report Years Considered
Figure 11. Global Atrophic Gastritis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Atrophic Gastritis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Atrophic Gastritis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Atrophic Gastritis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Atrophic Gastritis Treatment Market Share by Players in 2020
Figure 16. Global Top Atrophic Gastritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atrophic Gastritis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Atrophic Gastritis Treatment Revenue in 2020
Figure 18. Global Atrophic Gastritis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Atrophic Gastritis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Atrophic Gastritis Treatment Market Share by Type (2016-2027)
Figure 22. North America Atrophic Gastritis Treatment Market Share by Application (2016-2027)
Figure 23. North America Atrophic Gastritis Treatment Market Share by Country (2016-2027)
Figure 24. United States Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Atrophic Gastritis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Atrophic Gastritis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Atrophic Gastritis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Atrophic Gastritis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Atrophic Gastritis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Atrophic Gastritis Treatment Market Share by Region (2016-2027)
Figure 40. China Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Atrophic Gastritis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Atrophic Gastritis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Atrophic Gastritis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Atrophic Gastritis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Atrophic Gastritis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Atrophic Gastritis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Atrophic Gastritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Atrophic Gastritis Treatment Business (2016-2021)
Figure 60. PERNIX Therapeutics Revenue Growth Rate in Atrophic Gastritis Treatment Business (2016-2021)
Figure 61. Perrigo Pharmaceutical Revenue Growth Rate in Atrophic Gastritis Treatment Business (2016-2021)
Figure 62. Teva Pharmaceutical Revenue Growth Rate in Atrophic Gastritis Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の萎縮性瘢痕治療市場規模・現状・予測（2021年-2027年） Atrophic scars are scars named after the dysfunction they cause. More common after deep burn healing. Because of scar contraction, which may lead to shape changes and dysfunction, long-term scar contracture can affect the development of bones, muscles, blood vessels, nerves and other tissues, should…- 世界の胃炎治療薬市場規模・現状・予測（2021年-2027年） Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and …
- 世界の胃炎治療薬市場規模・現状・予測（2021年-2027年） Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and …
- 世界の胃炎治療市場規模・現状・予測（2021年-2027年） Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and …
- 世界の眼炎症治療市場規模・現状・予測（2021年-2027年） Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the …